Jozine ter Maaten

‘Personalized treatment’ for acute #heartfailure is the main take-home message from the #PUSH trial, just presented at #ESCCongress @kevin_damman @iebeldhuis @WilfriedMullens @JeroenDauw @FH_Verbrugge @PieterMartensMD @HFA_President @MarcoMetra @AlexMebazaa @AdriaanVoors

RT @HFA_President: 🫀Ready to take your expertise in advanced heart failure to the next level? Join us in Vienna for the HFA Advanced Heart Failure Course 2027! Two days of inspiring discussions, practical insights, & interactive learning with leading experts & colleagues passionate about improving advanced heart failure care. 📍Vienna, Austria 📍4-5 February 2027 Register here🔗: @escardio #HeartFailure #AdvancedHeartFailure #HFA_ESC @kevin_damman @MajaCikes @WilfriedMullens @jozinetm @MarcoMetra @GianluSava @h_arfsten @GTersalvi

Join us in Vienna for the HFA Advanced Heart Failure Course 2027, taking place from 4 to 5 February 2027. Join us for two days of immersive learning focused on advanced heart failure care! 📍Vienna, Austria 📅 4-5 February 2027

RT @HFA_President: New #HFA_ESC Journal Club! Could #sotatercept offer a new therapeutic approach for pulmonary hypertension associated with #HFpEF? 🫀🫁 Join our next #HFAJournalClub as we discuss: - Understanding CpcPH-HFpEF and its haemodynamic characteristics - Key findings & limitations of the CADENCE trial - Sotatercept & emerging approaches targeting pulmonary vascular remodelling - Implications for future research & clinical management 📍Faculty: @mardigomberg @HelpMyBreathing @corneliacrm #ThomasGorter 📍19 Oct 2026 | 18:00 CET 📍Register now: #HFAyoung @escardio @h_arfsten @GTersalvi @jozinetm

RT @escardio: 👉 Are we embracing AI in our Cardiology field and in the training of young Cardiologists? @jozinetm & @DrMarkWestwood1 discuss this on the new #ESCTVToday episode. Don't miss it! #AIinCardiology #ESCDigital #DigitalCardiology

RT @gunnar_heine: Nephrology rocks #ESCCongress @willkidney @kevin_damman @RonGansevoort Diana Gorog @jozinetm #StampOnCKD before a really huge audience 2026 @escardio @ERAkidney CKD GL "Jetzt wächst zusammen, was zusammengehört" (Now, what belongs together is growing together) Willi Brandt

RT @slumberbell: 🚨BREAKING NEWS from #ESCCongress: The first 1️⃣ ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease are here!🫀🫘 The new approach: STAMP on CKD 📍 S-Screen: All patients with CVD should be screened for CKD using both eGFR and spot urine ACR; not creatinine alone 📍 T-Triage & stage: CKD is diagnosed when eGFR <60 mL/min/1.73 m² and/or uACR ≥3 mg/mmol persists for ≥3 months 📍 A-Address risk: Smoking cessation, weight control, physical activity and an SBP target of 120-129 mmHg, when tolerated 📍ACEi/ARB, statin-based therapy and SGLT2 inhibitors are recommended in the majority of patients with CKD, according to the individual indication & kidney function 📍Diabetic CKD with albuminuria, add GLP-1 RA & non-steroidal MRA when appropriate 📍 M-Modify CVD management: CKD changes drug pharmacokinetics and increases the risks of hyperkalaemia, bleeding and AKI; but necessary cardiovascular treatment should not be unnecessarily delayed 📍In HF with CKD, SGLT2 inhibitors & loop diuretics for congestion are recommended irrespective of LVEF, with additional therapy guided by EF and eGFR; overall there is limited evidence when eGFR <30 mL/min/1.73 m² 📍 P-Plan services: identify high-risk patients, minimize CKD-related treatment delays & strengthen multidisciplinary care Read more📚: @escardio #ESCGuidelines #CKD #CVprev #Prevention #CVD @kevin_damman @jozinetm

RT @HFA_President: #ESCCongress 2026 starts today! 🇩🇪🫀 Over the next four days, Munich will bring together the global cardiovascular community for groundbreaking science, inspiring discussions, and meaningful connections. Interested in #heartfailure? Follow our #HFA_ESC Social Media Ambassadors for heart failure-related science, clinical takeaways, expert perspectives, and highlights, shared live from the Congress.📱@corneliacrm @slumberbell @AmrAbdin10 Whether you’re joining us in Munich or following from afar, join the conversation and share the moments that inspire you. Let’s get started! 📚 @escardio @WilfriedMullens @MarcoMetra @GianluSava @jozinetm @h_arfsten @GTersalvi @SotiriaLiori @_antocannata

RT @HFA_President: 📢 Upcoming #HFA_ESC Journal Club HF Hospitalisation as an Endpoint in Trials: The Holy Grail? HF hospitalisations are among the most commonly used endpoints in contemporary HF trials. But how well do they reflect mortality risk & meaningful treatment benefit? Join us for an engaging discussion on the strengths, limitations, & future of HF hospitalisation endpoints with the outstanding faculty: Prof. @GianluSava, Drs. @j_sokolska, @DrSamStraw, & @GTersalvi 🗓️ Thursday, 18 June 2026 🕕 18:00-19:00 CEST Register now🔗: #HFAYoung @escardio @MarcoMetra @WilfriedMullens @jozinetm @h_arfsten

RT @HFA_President: 🚨Last chance to apply! The call for applications to join the HFA Committees 2026-2028 closes next Monday (15 June).   Joining an HFA Committee means:
📍 Contributing to key scientific and educational initiatives
📍Expanding your international network
📍Helping shape the future of the field   👉 Apply today #HFA_ESC @escardio @WilfriedMullens @MarcoMetra @jozinetm @h_arfsten

RT @escardio: HFA Wrap-up by ESC TV – #HeartFailure26 Day 1 🎥 with Brenda Moura & @ShelleyZieroth, hosted by @jozinetm What a start to #HeartFailure26! End your day with HFA Wrap-up by ESC TV, your essential recap from Heart Failure 2026. From the day’s biggest scientific highlights to expert insights and clinical perspectives, this session brings together the key moments shaping the future of heart failure care. Hear leading experts reflect on major studies, emerging trends, and the latest data - all distilled into one engaging end-of-day discussion. Whether you joined us onsite or online, stay fully connected with the science driving tomorrow’s advances in heart failure. Let’s get ready for even more tomorrow! ✨ #HFA_ESC #Cardiology #ESCTV #HeartFailure @HFA_President

Results of first #LBCT at the #heartfailure26 ✨ Early discharge with subcutaneous furosemide compare to SoC results in 4️⃣ more days alive and out of the hospital at 30 days ❓want to know more about this? Check out the journal club at the ESC TV studio on Monday 🎥

And we’re off 🏁 Fantastic first morning of #heartfailure26 Packed sessions, great atmosphere, exciting new science 📸

RT @slumberbell: The HFA Career Café is back at #HeartFailure26 ☕ This is your chance to connect 1:1 with leading heart failure experts & receive personalised guidance on your career path whether clinical, academic, or research-focused 📚 First come-first served & the space is limited, so don’t miss your chance! 👉 Apply now: #HFAyoung @jozinetm @MarcoMetra @escardio @HFA_President #HFA_ESC

RT @HFA_President: Join us for the upcoming #HFA_ESC Journal Club as we explore #heartfailure recovery through the lens of the #WITHDRAW_AF trial 📅 23 March 2026 ⏰ 18:00-19:00 CET This session will review the rationale, design, & key findings of WITHDRAW-AF trial, placing it in the context of landmark trials such as TRED-HF & STOP-CRT, while addressing one of the most important questions in HFimpEF: 👉 Can we safely withdraw therapy & in whom? Faculty: Dr. #FelixLindberg, Assoc. Prof @drsunnyprabhu , Dr. @bp_halliday, & Dr. #BernadetSantema Register here: #HFAJournalClub #HFAyoung @jozinetm @MarcoMetra @escardio

Applications are now OPEN for our Summer School Cardiology! 🫀 📍 Groningen, The Netherlands | 📅 July 6–10, 2026 🎓 An international program for medical students, PhD candidates, postdoctoral researchers, and early-career clinicians with a strong interest for cardiology research

Dive into five core themes: Heart Failure, Rhythm Disorders, Ischemic Heart Disease, Cardio-Oncology &amp; Cardiomyopathies, and Future Research in Cardiology. 👉 Apply Now! 👉 Program details 👉 Contact summerschoolcardiology@umcg.nl

@CardiologyUmcg @kevin_damman

RT @HFA_President: 🎙️New HFA Cardiotalk episode is out! Join Dr #FelixLindberg & Prof @MariannaFonta11 as they dive into the rapidly changing world of cardiac #amyloidosis treatment In this episode, they’ll discuss about: 📍The pathophysiology of AL and ATTR cardiac amyloidosis 📍Key epidemiological insights from recent years 📍How the therapeutic landscape has transformed, from stabilizers to silencers 📍Emerging treatments, including anti‑amyloid antibodies 📍Practical guidance on patient selection and clinical decision‑making 📍Red flags clinicians should recognize for early diagnosis🚩 🎧 Listen here : #HFA_ESC #HFAYoung @escardio @MarcoMetra @jozinetm

RT @HFA_President: #Digitoxin in #HFrEF: what did DIGIT-HF really show? Join the upcoming #HFA_ESC Journal Club for a comprehensive review of digitoxin pharmacology, DIGIT-HF design & findings, & what’s the implication for clinical practice & contemporary #HF management 🗓️When: 27 January 26 | 18:00-19:00 CET 📚Faculty: Prof #UdoBavendiek, Prof #PetervanderMeer, Dr @Jolie_Bruno_, & Dr @corneliacrm Register now: @escardio @MarcoMetra @jozinetm #HFAyoung @JBauersachsMD #HeartFailure

🫀 HFA Journal Club is back! Join us for a sharp discussion on digitoxin in heart failure (HFrEF) and what the evidence really says DIGIT HF trial 📅 27 Jan | 💻 Online (free for HFA members) 👉 #HFA #HFAJournalClub #HFAYoung @HFA_President @escardio

RT @escardio: This #InternationalEducationDay, we celebrate the young cardiovascular professionals shaping the future of cardiology through the ESC Young Community. As active contributors, they’re driving tomorrow’s knowledge through: 🔹 Innovative educational resources 🔹 The ESC 365 Young Track 🔹 The ESC Mentoring Platform Discover how young voices are making an impact 👉 #ESCardioEd #ESCYoung #ESC365 @jozinetm @slumberbell @_antocannata @cfcamm @mrubini @martha_kyriakou @KralerSimon @CharlesFauvel @eromerodorta @aleks_gasecka @SMosteoru @ManningerMartin @JohannesGrand

RT @HFA_President: How to optimise GDMT for complex #HeartFailure patients, LIVE today! Join Drs @AlexMebazaa @HSkouri @jozinetm @corneliacrm for this #HFA_ESC webinar covering: 📍Gaps between current evidence & real-world #HF management 📍Managing GDMT in renal dysfunction, hypotension & elderly 📍NT-proBNP to guide therapy 📍Turning evidence into local practice ⏰Today, 19 Jan 2026 | 18:00-19:00 CET 👉Register now: @escardio @MarcoMetra

🫀 Don’t miss the HFA webinar on optimising GDMT! 📅 19 Jan 2026 | ⏰ 18:00 CET
💻 Free for HFA members
👉 @HFA_President @AlexMebazaa @HSkouri @jozinetm @escardio @slumberbell @SotiriaLiori #HFAYoung